Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/12/038427
CTRI/2021/12/038427
Completed
未知

A Retrospective, Non-Interventional, Multi-Center Study to Assess Treatment Pattern in Alcohol Withdrawal Syndrome Patients during Hospitalization and Post Discharge Compliance

Abbott Healthcare Pvt Ltd0 sites1,000 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: F102- Alcohol dependence

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F102- Alcohol dependence
Sponsor
Abbott Healthcare Pvt Ltd
Enrollment
1000
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 4, 2022
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Male/female of \>\= 18 years of age at the time of data collection.
  • •2\.Patient admitted with AWS Symptoms
  • •3\.Patient with at least 3 months documented follow ups

Exclusion Criteria

  • •1\.Patient was directly admitted to the ICU when alcohol withdrawal treatment was initiated.
  • •2\.Patient who had a positive urine toxicology screen for BZDs (unless given for the treatment of alcohol withdrawal), barbiturates, opiates (unless administered at URMC prior to sampling), or other illegal substances.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A study to see the prevalence of HER2 low, clinical characteristics, treatment patterns, and outcomes in patients with HER2 negative locally advanced or metastatic breast cancer who progressed on systemic anticancer therapy.Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
CTRI/2024/03/063553AstraZeneca Pharma India Ltd
Recruiting
Not Applicable
A prospective, non-interventional, multicenter, observational study to investigate the effectiveness and safety of Sevikar HCT® Tablet in hypertensive patients with type 2 diabetes mellitus or prediabetes in KoreaDiseases of the circulatory system
KCT0006918Daiichi-Sankyo Korea3,000
Not yet recruiting
Phase 4
A Observational non-interventional Post Marketing Surveillance (PMS) Study of RituxiRelTM RN(Rituximab)in Patients with Pemphigus VulgarisHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2020/06/025819Reliance Life Sciences Pv Ltd
Not yet recruiting
Phase 4
A Non-interventional, observational Post Marketing Surveillance (PMS) Study of AdaliRelTM (Adalimumab) in Patients With Active Rheumatoid arthritis.
CTRI/2020/04/024644Reliance Life Sciences Pv Ltd
Unknown
Not Applicable
An observational study to understand usage and effect of daclatasvir use with sofosbuvir for the treatment of adults with chronic hepatitis C infections
CTRI/2017/07/009056Torrent Pharmaceuticals Ltd54